NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 179 filers reported holding NOVAVAX INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $10,000 | +100.0% | 5,371 | +104.1% | 0.00% | – |
Q3 2018 | $5,000 | +25.0% | 2,631 | -2.9% | 0.00% | – |
Q2 2018 | $4,000 | – | 2,709 | +782.4% | 0.00% | – |
Q2 2017 | $0 | – | 307 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 307 | 0.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 307 | -96.9% | 0.00% | – |
Q3 2016 | $21,000 | -70.8% | 9,907 | 0.0% | 0.00% | – |
Q2 2016 | $72,000 | +5.9% | 9,907 | -23.7% | 0.00% | – |
Q1 2016 | $68,000 | +58.1% | 12,984 | +148.4% | 0.00% | – |
Q4 2015 | $43,000 | +126.3% | 5,228 | +95.0% | 0.00% | – |
Q3 2015 | $19,000 | -95.7% | 2,681 | -95.0% | 0.00% | -100.0% |
Q1 2015 | $446,000 | -73.3% | 53,966 | -86.5% | 0.00% | -50.0% |
Q3 2014 | $1,668,000 | -10.8% | 400,000 | -1.2% | 0.00% | 0.0% |
Q2 2014 | $1,870,000 | – | 404,730 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |